Diagnostics Platform Curelo Secures $100K Funding from IIMA’s CIIE.CO
- ByStartupStory | October 12, 2023
Curelo, a diagnostics platform founded in 2022 by Dr. Arpit Jayswal, has announced a successful fundraising round, securing $100,000 in funding from IIMA’s CIIE.CO. The platform specializes in enabling patients to conveniently book at-home blood sample collections and promptly receive their blood reports from a lab of their choice. Powered by a team of phlebotomists, Curelo offers sample collection within just 60 minutes of booking and ensures delivery to the selected lab. Patients can also find labs on the platform based on test availability, pricing, and turnaround time.
Over the last ten months of operation, Curelo has established partnerships with more than 1,350 labs, processed over 125,000 orders, and currently maintains a monthly run rate of INR 55 lakhs, with a month-on-month growth rate of 30%. Curelo is now setting its sights on expanding into radiology and blood bank aggregators in the near future.
Mr. Vipul Patel, Partner – Seed Investments at CIIE.CO, expressed his enthusiasm, saying, “Arpit’s experience in running a chain of multi-specialty hospitals and diagnostic labs gives him deep insights into the customer pain points. We are excited to partner with the Curelo team and look forward to helping them scale their business.”
Exciting news! We’re now on WhatsApp Channels too. Subscribe today by clicking the link and stay updated with the latest insights in the startup ecosystem! Click here!
Dr. Arpit Jayswal, Founder and CEO of Curelo, stated, “We are excited to have CIIE.CO back Curelo. Their conviction reflects the immense potential in our platform and the diagnostic aggregator sector. Our primary focus is scaling nationwide, optimizing the user experience, and standardizing sample collection, aiming to serve over 1,000 home samples daily by year-end. We are keen to have CIIE.CO support us in this journey with their exceptional sector understanding and network.”
Follow Startup Story
Related Posts
